FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

385084005: Conventional release sublingual tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479346016 Sublingual tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3633870019 Conventional release sublingual tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3633871015 Conventional release sublingual tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sublingual tablet Is a Tablet false Inferred relationship Some
Sublingual tablet Is a Oromucosal AND/OR gingival dosage form false Inferred relationship Some
Sublingual tablet Is a Tablet false Inferred relationship Some
Sublingual tablet Is a Orodispersible tablet false Inferred relationship Some
Sublingual tablet Has dose form administration method (attribute) Administer (administration method) true Inferred relationship Some
Sublingual tablet Has dose form intended site (attribute) Sublingual (intended site) true Inferred relationship Some
Sublingual tablet Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
Sublingual tablet Has basic dose form (attribute) Tablet true Inferred relationship Some
Sublingual tablet Is a Sublingual dose form (dose form) true Inferred relationship Some
Sublingual tablet Has dose form transformation (attribute) No transformation true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Glyceryl trinitrate 2 mg prolonged-release buccal tablet Has manufactured dose form False Sublingual tablet Inferred relationship Some
Product containing precisely glyceryl trinitrate 1 milligram/1 each prolonged-release buccal tablet (clinical drug) Has manufactured dose form False Sublingual tablet Inferred relationship Some
Product containing precisely glyceryl trinitrate 3 milligram/1 each prolonged-release buccal tablet (clinical drug) Has manufactured dose form False Sublingual tablet Inferred relationship Some
Product containing precisely glyceryl trinitrate 5 milligram/1 each prolonged-release buccal tablet (clinical drug) Has manufactured dose form False Sublingual tablet Inferred relationship Some
Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) Has manufactured dose form False Sublingual tablet Inferred relationship Some
Nitroglycerin 300micrograms tablet Has manufactured dose form False Sublingual tablet Inferred relationship Some
Glyceryl trinitrate 400 microgram sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Nitroglycerin 0.6mg tablet Has manufactured dose form False Sublingual tablet Inferred relationship Some
Isosorbide dinitrate 5mg sublingual tablet Has manufactured dose form False Sublingual tablet Inferred relationship Some
Product containing precisely isosorbide dinitrate 10 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Isosorbide dinitrate 5 mg sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely isosorbide dinitrate 2.5 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Apomorphine hydrochloride 2 mg sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Zolpidem 5mg sublingual tablet Has manufactured dose form False Sublingual tablet Inferred relationship Some
Zolpidem 10mg sublingual tablet Has manufactured dose form False Sublingual tablet Inferred relationship Some
Nicotine 2mg sublingual tablet Has manufactured dose form False Sublingual tablet Inferred relationship Some
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely dihydroergotamine mesilate 1 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Has manufactured dose form False Sublingual tablet Inferred relationship Some
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet Has manufactured dose form False Sublingual tablet Inferred relationship Some
Ergotamine tartrate 2 mg sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Asenapine 5 mg sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Asenapine 10 mg sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely glyceryl trinitrate 600 microgram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely glyceryl trinitrate 300 microgram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely glyceryl trinitrate 500 microgram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Sublingual tablet Inferred relationship Some
Zolpidem tartrate 5 mg sublingual tablet Has manufactured dose form True Sublingual tablet Inferred relationship Some

Reference Sets

GB English

US English

Back to Start